Massachusetts General Hospital: Neoplasm Metastasis trials

The registry lists 10 Neoplasm Metastasis studies with Massachusetts General Hospital as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 1Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the LiverRecruitingNCT07364474Not applicable
• Pemigatinib + Afatinib in Advanced Refractory Solid TumorsRecruitingNCT06302621Phase 1
• IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis FracturesRecruitingNCT04842266
• A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLCCompletedNCT02314364Phase 2Results posted
• Tivozanib + Enzalutamide in Adv Prostate CancerTerminatedNCT01885949Phase 2Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• Niraparib in Tumors Metastatic to the CNSActive, not recruitingNCT04992013Phase 2
• Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
• Biopsies of Cancer Patients for Tumor Molecular CharacterizationCompletedNCT01061944
• Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic MetastasesCompletedNCT00465023Not applicable